5810
J. Am. Chem. Soc. 2001, 123, 5810-5811
extensive molecular mechanics simulations,11 which suggested
that such structures would be conformationally rigid, and able to
present functionality in a spatially defined manner. For example,
molecular models of 4 docked to lipid A suggested good surface
complimentarity between the two structures. It was anticipated
that variation of the acyl groups (X, Y) would allow for tuning
of the structure to optimize affinity; in particular, we anticipated
that employing amino acids as the “Y” groups would improve
the solubility of 4 in water, while positioning amino groups
optimally for hydrogen bonding to occur between 4 and the
phosphate, amide, and ester moieties of 2.
Highly Substituted ter-Cyclopentanes as Receptors
for Lipid A
Robert D. Hubbard,‡ Scott R. Horner,§,† and
Benjamin L. Miller*,†,‡
Department of Chemistry, Department of Biophysics, and
The Center for Future Health, UniVersity of Rochester
Rochester, New York 14627
ReceiVed October 18, 2000
ReVised Manuscript ReceiVed January 18, 2001
The design and synthesis of simple organic receptors capable
of high-affinity binding to carbohydrates in aqueous solution
presents a substantial challenge to our understanding of molecular
structure and the processes which underly molecular recognition.1
In essence, a simple sugar like glucose (1) is no more than an
oriented collection of hydroxy groups, differing little from bulk
water. Because of this, the vast majority of receptors for
carbohydrates reported thus far have been studied only in organic
solvents,2 since competition between the solvent and the targeted
carbohydrate for binding is not as much of a problem. Of the
carbohydrate receptors examined in aqueous solution thus far,
the best bind simple sugars with affinities (dissociation constants,
KD) in the millimolar range.3
As part of a continuing program in the development of new
methods for the recognition of biologically significant structures,4
we became interested in the possibility of employing highly
substituted, stereoregular oligomers of cyclopentane as receptors
for simple carbohydrates, liposaccharides, and oligosaccharides.
In particular, lipid A (2) represented an attractive target for
binding, both because of its structural features and due to its
biological role as the conserved portion of lipopolysaccharide
(LPS). LPS is a primary constituent of the outer cellular membrane
of Gram-(-) bacteria,5 and is perhaps better known as bacterial
endotoxin, the causative agent of sepsis.6 Antibiotics such as the
polymyxin family of cyclic peptides7 (i.e. polymyxin B, 3) derive
their effectiveness against sepsis through an ability to bind to
and neutralize bacterial endotoxin, primarily mediated by interac-
tions with lipid A.8 However, polymyxin is problematic as a
therapeutic agent both because of its complex structure (rendering
it impractical to synthesize in quantity) and because of its side
effects (acute renal toxicity,9 among others). Therefore, the
development of new lipid A-binding, endotoxin-neutralizing
compounds is a problem of potential medical significance10 as
well as a fundamental problem in molecular recognition. Our
contention that highly substituted oligocyclopentanes such as 4
might be attractive receptors for carbohydrates was based on
Our synthesis of 4 was designed with an eye toward both
producing its three rings and 10 stereocenters in as few steps as
possible and developing methodology that would be amenable
to both large-scale and combinatorial library synthesis. As shown
in Scheme 1, we began by converting norbornene (5) to the known
cis-cyclopentane-1,3-dialdehyde12 (6) via Sharpless dihydroxyl-
ation13 followed by sodium periodate-metiated oxidative cleavage
of the diol.14 Subsequent treatment of the dialdehyde with
Horner-Wadsworth-Emmons reagent 7 under standard condi-
tions (potassium tert-butoxide as base in THF) provided the bis
R,â-unsaturated ester 8 in 90% yield and >20:1 EE:EZ selectivity.
Our initial attempts to employ 8 as the dienophile in a bidirectional
Diels-Alder reaction with cyclopentadiene using standard Lewis
acid catalysts were unsuccessful; however, a hybrid 0.5:0.05
AlCl3-Al(CH3)3 catalyst system we have previously described15
provided for the smooth conversion of 8 to double Diels-Alder
cycloadduct 9 in 87% yield and 94:6 endo,endo-endo,exo
selectivity.
‡ Department of Chemistry.
With all of the carbocyclic skeleton and stereogenic centers of
4 installed, it remained for us to set the peripheral functionality.
Reduction of the cycloadduct 9 with LiAlH4 provided a diol in
53% yield, which was derivatized with benzoyl chloride to yield
§ Department of Biophysics.
† The Center for Future Health.
(1) Davis, A. P.; Wareham, R. S. Angew. Chem., Int. Ed. 1999, 38, 2978-
2996. The synthesis of carbohydrate mimetics (as opposed to receptors) has
also been an active area of research; for a review, see: Sears, P.; Wong, C.-
H. Angew. Chem., Int. Ed. 1999, 38, 2300-2324.
(10) For other examples of lipid A-binding compounds and their develop-
ment as therapeutic agents, see: (a) Rustici, A.; Velucchi, M.; Faggioni, R.;
Sironi, M.; Ghezzi, P.; Quataert, S.; Green, B.; Porro, M. Science 1993, 259,
361-365. (b) Vaara, M.; Porro, M. Antimicrob. Agents Chemother. 1996,
40, 1801-1805. (c) Li, C.; Budge, L. P.; Driscoll, C. D.; Willardson, B. M.;
Allman, G. W.; Savage, P. B. J. Am. Chem. Soc. 1999, 121, 931-940.
(11) Structures were constructed, minimized, and docked using Macromodel
6.0 (Schroedinger, Inc.) and the AMBER* force field; details of our
computational studies of the conformational properties of substituted oligo-
cycloalkanes will be disclosed in due course.
(2) For a recent example, see: Mazik, M.; Bandmann, H.; Sicking, W.
Angew. Chem., Int. Ed. 2000, 39, 551-554.
(3) (a) Kobayashi, K.; Asakawa, Y.; Kato, Y.; Aoyama, Y. J. Am. Chem.
Soc. 1992, 114, 10307. (b) Yanagihara, R.; Aoyama, Y. Tetrahedron Lett.
1994, 35, 9725. (c) Poh, B.-L.; Tan, C. M. Tetrahedron 1993, 49, 9581.
(4) Klekota, B.; Miller, B. L. Tetrahedron 1999, 55, 11687-11697.
(5) Young, L. S.; Martin, W. J.; Meyer, R. D.; Weinstein, R. J.; Anderson,
E. T. Ann. Intern. Med. 1977, 86, 456-471.
(6) (a) Raetz, C. R. H. Annu. ReV. Biochem. 1990, 59, 129-170. (b)
Ulevitch, R. J.; Tobias, P. S. Curr. Opin. Immunol. 1994, 6, 125-130.
(7) Chapman, T. M.; Golden, M. R. Biochem. Biophys. Res. Commun. 1972,
46, 2040-2047.
(12) Wiberg, K. B.; Saegebarth, K. A. J. Am. Chem. Soc. 1957, 79, 2822-
2824.
(13) Becker, H.; Soler, M. A.; Sharpless, K. B. Tetrahedron 1995, 51,
1345-1376.
(8) (a) Morrison, D. C.; Jacobs, D. M. Immunochemistry 1976, 13, 813-
818. (b) David, S. A.; Balasubramanian, K. A.; Mathan, V. I.; Balaram, P.
Biochim. Biophys. Acta 1992, 1165, 145-152.
(14) 6 has also been prepared from norbornene via ozonolysis (Trautmann,
W.; Musso, H. Chem. Ber. 1981, 114, 982-989); however, in our hands this
procedure was generally lower yielding than the dihydroxylation-oxidative
cleavage method.
(9) (a) Craig, W. A.; Turner, J. H.; Kunin, C. M. Infect. Immun. 1974, 10,
287. (b) D. Rifkind J. Bacteriol. 1967, 93, 1463. Kunin, C. M. J. Infect.
Diseases 1970, 121, 55-64.
(15) Hubbard, R. D.; Miller, B. L. J. Org. Chem. 1998, 63, 4143-4146.
10.1021/ja003712y CCC: $20.00 © 2001 American Chemical Society
Published on Web 05/26/2001